---
schema_version: "secwatch.filing_event.v1"
accession: "0001516551-24-000034"
form_type: "8-K"
ticker: "SKYE"
cik: "0001516551"
company_name: "Skye Bioscience, Inc."
filed_at: "2024-03-04T23:59:59+00:00"
generated_at: "2026-06-05T04:41:28.526742+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Skye Bioscience appoints Dr. Annalisa Jenkins to board; director Dalesandro to resign Aug 1

## Summary
- Dr. Annalisa Jenkins appointed to board effective Feb 29, 2024, filling newly created eighth seat.
- Dr. Jenkins receives annual cash retainer of $40,000 plus committee retainers; option for 40,000 shares vesting over 1 year.
- Director Margaret Dalesandro to resign effective Aug 1, 2024, citing no disagreement with company.
- Dr. Jenkins brings 25+ years pharma/biotech experience including roles at Merck Serono, BMS, and as CEO of Dimension Therapeutics.

## SEC filing metadata
- accession: 0001516551-24-000034
- form_type: 8-K
- ticker: SKYE
- cik: 0001516551
- company_name: Skye Bioscience, Inc.
- filed_at: 2024-03-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1516551/000151655124000034/0001516551-24-000034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1516551/000151655124000034/skye-20240229.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001516551-24-000034
- JSON: https://secwatch.observer/filing/0001516551-24-000034.json
- Plain text: https://secwatch.observer/filing/0001516551-24-000034.txt

## Key facts
- Executive change
  Margaret Dalesandro resigned as Director at Skye Bioscience, Inc..
  - Action: resigned
  - Role: Director
  source text: Margaret Dalesandro, Ph.D. informed the Board of her intent to resign as a member of the Board, effective August 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1516551/000151655124000034/0001516551-24-000034-index.htm
- Executive change
  Annalisa Jenkins was appointed as Director at Skye Bioscience, Inc..
  - Action: appointed
  - Role: Director
  source text: appointed Annalisa Jenkins, M.B.B.S., F.R.C.P. to fill the vacancy created by such increase.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1516551/000151655124000034/0001516551-24-000034-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.